Costimulatory receptor molecules that mediate the signalling transduction pathways of T-cell proliferation, differentiation and activation, such as cluster of differentiation 27 (CD27) and 28 (CD28), have been proposed as important immunomodulation targets in cancer treatments31,32. Here, CD27 is linked to cancer.